Global Partners

USAID supports, enhances, and provides leadership to many global partnerships in the health sector. These partnerships complement USAID's existing programs and, by leveraging new resources, expertise, and technologies, offer greater opportunities to achieve development objectives.

• Global Alliance for TB Drug Development
  USAID's agreement with the Global Alliance for TB Drug Development supports the Alliance's program to identify promising lead compounds and drug candidates, carry out clinical trials of drug candidates, and to move candidate compounds along the drug development pipeline to registration.
  
  
• Global TB Drug Facility (GDF)
  USAID provides support for grants for TB drugs, technical assistance and monitoring of GDF grant recipients, and pre-qualification of TB drug suppliers. USAID financing also helps the GDF operate a driect procurement service through which countries, NGOs, and others donors can purchase quality-assured drugs at competitive prices.
  
  
• Green Light Committee (GLC)
  The Green Light Committee (GLC ) Initiative helps countries gain access to high-quality second-line anti-TB drugs, so they can provide treatment for people with MDR-TB in line with the WHO guidelines, the latest scientific evidence, and country experiences. The Initiative consists of a secretariat, the Green Light Committee (an expert review and WHO advisory body) and the Global Drug Facility (GDF) (the drug procurement arm of the Initiative). The Global Fund requires that all proposals that include second-line drugs for TB be reviewed by the GLC. USAID has supported the GLC Initiative since it was established in 2000. The Agency’s assistance enables the GLC to provide technical assistance to GLC applicants and Global Fund grant recipients.
  
  
• Stop TB Partnership
  USAID was heavily involved in the development of the “STOP TB Partnership’s Global Plan to Stop TB 2006-2015, and USAID’s programs are fully in line with the strategies and objectives described in that plan. USAID support is provided to the Stop TB Partnership for country level advocacy, communications and social mobilization activities, the development of national STOP TB partnerships, and monitoring of global financial support for TB control.
  
  
• World Health Organization (WHO)
  USAID support enables WHO to implement key activities such as global monitoring and surveillance; global surveillance for TB drug resistance; coordination of technical assistance to countries, including support for the successful implementation of Global Fund grants; development and dissemination of policies and guidelines and provision of technical assistance related to elements of the STOP TB Strategy (such as , public-private mix, Directly Observed Treatment, Short Course (DOTS), prevention and control of Multidrug-Resistant (MDR) TB, Green Light Committee for MDR TB, lab strengthening, technical assistance to support TB-HIV/AIDS activities, and human resource development for TB control).